Skip to main content
Equibles

PANAGORA ASSET MANAGEMENT INC

Position in VIR — Vir Biotechnology, Inc.

CIK 883677 Boston, MA
Back to VIR Full portfolio

Position in VIR

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$3,813,760
+$450,589 QoQ
Shares Held
374,265
-0.3% QoQ
Ownership
0.221%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#54
of 237 holders
Holding Since
Mar 2023
7 quarters on record
Voting authority Sole 75% Shared 0% None 25%

Common Shares in VIR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

PANAGORA ASSET MANAGEMENT INC holds $623,499,718 across 77 Biotechnology names. VIR ranks #28 (0.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
 175,291 $109,300,950
2 INCY
Incyte Corp
 881,889 $99,970,937
3 XENE
Xenon Pharmaceuticals Inc.
 664,031 $40,080,911
4 MIRM
Mirum Pharmaceuticals, Inc.
 337,461 $39,506,559
5 TVTX
Travere Therapeutics, Inc.
 490,724 $27,878,030
6 JAZZ
Jazz Pharmaceuticals plc
 104,935 $25,286,186
7 RLAY
Relay Therapeutics, Inc.
 1,291,182 $24,158,015
8 CLDX
Celldex Therapeutics, Inc.
 572,538 $21,304,138

All Filings in VIR

Export CSV
7 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,813,760 374,265
2026-03-31 $3,363,171 375,354
2025-12-31 $2,238,884 371,291
2025-09-30 $2,057,981 360,417
2025-06-30 $490,528 97,327
2023-12-31 $950,830 94,516
2023-03-31 $487,576 20,953